Invasive Endocervical Adenocarcinoma

Andrea Diaz De Vivar(Cleveland Clinic), Andres A. Roma(Cleveland Clinic), Kay J. Park(Cleveland Clinic), Isabel Alvarado‐Cabrero(Cleveland Clinic), Golnar Rasty(Cleveland Clinic), José Chanona-Vilchis(Cleveland Clinic), Yoshiki Mikami(Cleveland Clinic), Sung Ran Hong(Cleveland Clinic), Brent Arville(Cleveland Clinic), Norihiro Teramoto(Cleveland Clinic), Rouba Ali‐Fehmi(Cleveland Clinic), Joanne Rutgers(Cleveland Clinic), Farah Tabassum(Cleveland Clinic), Denise Barbuto(Cleveland Clinic), Irene Aguilera‐Barrantes(Cleveland Clinic), Ali Brown(Cleveland Clinic), Dean Daya(Cleveland Clinic), Elvio G. Silva(Cleveland Clinic)
International Journal of Gynecological Pathology
September 27, 2013
Cited by 151

Abstract

The management of endocervical adenocarcinoma is largely based on tumor size and depth of invasion (DOI); however, DOI is difficult to measure accurately. The surgical treatment includes resection of regional lymph nodes, even though most lymph nodes are negative and lymphadenectomies can cause significant morbidity. We have investigated alternative parameters to better identify patients at risk of node metastases. Cases of invasive endocervical adenocarcinoma from 12 institutions were reviewed, and clinical/pathologic features assessed: patients' age, tumor size, DOI, differentiation, lymph-vascular invasion, lymph node metastases, recurrences, and stage. Cases were classified according to a new pattern-based system into Pattern A (well-demarcated glands), B (early destructive stromal invasion arising from well-demarcated glands), and C (diffuse destructive invasion). In total, 352 cases (FIGO Stages I-IV) were identified. Patients' age ranged from 20 to 83 years (mean 45), DOI ranged from 0.2 to 27 mm (mean 6.73), and lymph-vascular invasion was present in 141 cases. Forty-nine (13.9%) demonstrated lymph node metastases. Using this new system, 73 patients (20.7%) with Pattern A tumors (all Stage I) were identified. None had lymph node metastases and/or recurrences. Ninety patients (25.6%) had Pattern B tumors, of which 4 (4.4%) had positive nodes; whereas 189 (53.7%) had Pattern C tumors, of which 45 (23.8%) had metastatic nodes. The proposed classification system can spare 20.7% of patients (Pattern A) of unnecessary lymphadenectomy. Patients with Pattern B rarely present with positive nodes. An aggressive approach is justified in patients with Pattern C. This classification system is simple, easy to apply, and clinically significant.


Related Papers

No related papers found

Powered by citation graph analysis